Tel-eVax: A Genetic Vaccine Targeting Telomerase for Treatment of Canine Lymphoma

Journal of Translational Medicine - United Kingdom
doi 10.1186/s12967-018-1738-6
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Springer Science and Business Media LLC

Related search

Building a Better Lymphoma Vaccine

Nature
Multidisciplinary
2018English

Advancing Our Understanding and Treatment of Lymphoma With Spontaneous Canine Models

Hematological Oncology
MedicineCancer ResearchOncologyHematology
2019English

Telomerase: A Potential Diagnostic and Therapeutic Tool in Canine Oncology

Veterinary Pathology
Veterinary
2003English

Pharmacological Targeting of Valosin Containing Protein (VCP) Induces DNA Damage and Selectively Kills Canine Lymphoma Cells

BMC Cancer
Cancer ResearchOncologyGenetics
2015English

Household Chemical Exposures and the Risk of Canine Malignant Lymphoma, a Model for Human Non-Hodgkin’s Lymphoma

Environmental Research
BiochemistryEnvironmental Science
2012English

Constitutional Telomerase Mutations Are Genetic Risk Factors for Cirrhosis

Hepatology
MedicineHepatology
2011English

Umbralisib: Treatment for a Rare Lymphoma?

Cancer Discovery
Oncology
2019English

Establishment of a Bioluminescent Canine B-Cell Lymphoma Xenograft Model for Monitoring Tumor Progression and Treatment Response in Preclinical Studies

PLoS ONE
Multidisciplinary
2018English

Immunohistochemical Detection of Survivin in Canine Lymphoma

Journal of Comparative Pathology
Forensic MedicinePathologyVeterinary
2010English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy